Cargando…

Delta-Tocotrienol Modulates Glutamine Dependence by Inhibiting ASCT2 and LAT1 Transporters in Non-Small Cell Lung Cancer (NSCLC) Cells: A Metabolomic Approach

The growth and development of non-small cell lung cancer (NSCLC) primarily depends on glutamine. Both glutamine and essential amino acids (EAAs) have been reported to upregulate mTOR in NSCLC, which is a bioenergetics sensor involved in the regulation of cell growth, cell survival, and protein synth...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rajasinghe, Lichchavi Dhananjaya, Hutchings, Melanie, Gupta, Smiti Vaid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6468853/ https://www.ncbi.nlm.nih.gov/pubmed/30871192 http://dx.doi.org/10.3390/metabo9030050

Ejemplares similares

Delta-tocotrienol inhibits non-small-cell lung cancer cell invasion via the inhibition of NF-κB, uPA activator, and MMP-9
por: Rajasinghe, Lichchavi D, et al.
Publicado: (2018)

Inhibition of glucose metabolism prevents glycosylation of the glutamine transporter ASCT2 and promotes compensatory LAT1 upregulation in leukemia cells
por: Polet, Florence, et al.
Publicado: (2016)

Targeting of glutamine transporter ASCT2 and glutamine synthetase suppresses gastric cancer cell growth
por: Ye, Jianxin, et al.
Publicado: (2018)

The glutamine transporter ASCT2 (SLC1A5) promotes tumor growth independently of the amino acid transporter LAT1 (SLC7A5)
por: Cormerais, Yann, et al.
Publicado: (2018)

Homology Modeling Informs Ligand Discovery for the Glutamine Transporter ASCT2
por: Garibsingh, Rachel-Ann A., et al.
Publicado: (2018)

ASCT2 regulates glutamine uptake and cell growth in endometrial carcinoma
por: Marshall, A D, et al.
Publicado: (2017)

Transcriptomic Analysis of the Anticancer Effects of Annatto Tocotrienol, Delta-Tocotrienol and Gamma-Tocotrienol on Chondrosarcoma Cells
por: Pang, Kok-Lun, et al.
Publicado: (2022)

ASCT2 overexpression is associated with poor survival of OSCC patients and ASCT2 knockdown inhibited growth of glutamine‐addicted OSCC cells
por: Luo, Yijun, et al.
Publicado: (2020)

Pharmacological Blockade of ASCT2-dependent Glutamine Transport Leads To Anti-tumor Efficacy in Preclinical Models
por: Schulte, Michael L., et al.
Publicado: (2018)

Prognostic significance of amino-acid transporter expression (LAT1, ASCT2, and xCT) in surgically resected tongue cancer
por: Toyoda, M, et al.
Publicado: (2014)

Ag120-Mediated Inhibition of ASCT2-Dependent Glutamine Transport has an Anti-Tumor Effect on Colorectal Cancer Cells
por: Yu, Wei, et al.
Publicado: (2022)

Structural characterisation reveals insights into substrate recognition by the glutamine transporter ASCT2/SLC1A5
por: Scopelliti, Amanda J, et al.
Publicado: (2018)

ASCT2 is the primary serine transporter in cancer cells
por: Conger, Kelly O., et al.
Publicado: (2023)

SLC transporters ASCT2, B(0)AT1‐like, y(+)LAT1, and LAT4‐like associate with methionine electrogenic and radio‐isotope flux kinetics in rainbow trout intestine
por: To, Van P. T. H., et al.
Publicado: (2019)

Functional and Kinetic Comparison of Alanine Cysteine Serine Transporters ASCT1 and ASCT2
por: Wang, Jiali, et al.
Publicado: (2022)

ASCT2 and LAT1 Contribution to the Hallmarks of Cancer: From a Molecular Perspective to Clinical Translation
por: Lopes, Catarina, et al.
Publicado: (2021)

Cryo-EM structures of the human glutamine transporter SLC1A5 (ASCT2) in the outward-facing conformation
por: Yu, Xiaodi, et al.
Publicado: (2019)

Targeting ASCT2-mediated glutamine metabolism inhibits proliferation and promotes apoptosis of pancreatic cancer cells
por: Wang, Wenbin, et al.
Publicado: (2022)

Targeted Suppression and Knockout of ASCT2 or LAT1 in Epithelial and Mesenchymal Human Liver Cancer Cells Fail to Inhibit Growth
por: Bothwell, Paige J., et al.
Publicado: (2018)

Targeting ASCT2‐mediated glutamine uptake blocks prostate cancer growth and tumour development
por: Wang, Qian, et al.
Publicado: (2015)

A Novel ASCT2 Inhibitor, C118P, Blocks Glutamine Transport and Exhibits Antitumour Efficacy in Breast Cancer
por: Lyu, Xiao-Dan, et al.
Publicado: (2023)

NDRG2 ablation reprograms metastatic cancer cells towards glutamine dependence via the induction of ASCT2
por: Ding, Mingchao, et al.
Publicado: (2020)

Transmucosal Delivery of Tocotrienols From a Delta-Tocotrienol Powder: A Multidose Pharmacokinetic Study
por: Moon, Jordan, et al.
Publicado: (2022)

Epigenetic silencing of microRNA-137 enhances ASCT2 expression and tumor glutamine metabolism
por: Dong, J, et al.
Publicado: (2017)

LAT1 and ASCT2 Related microRNAs as Potential New Therapeutic Agents against Colorectal Cancer Progression
por: Dias, Francisca, et al.
Publicado: (2021)

Regulation of Obesity and Metabolic Complications by Gamma and Delta Tocotrienols
por: Zhao, Lu, et al.
Publicado: (2016)

Necroptosis Induced by Delta-Tocotrienol Overcomes Docetaxel Chemoresistance in Prostate Cancer Cells
por: Montagnani Marelli, Marina, et al.
Publicado: (2023)

ASCT2 (SLC1A5)-dependent glutamine uptake is involved in the progression of head and neck squamous cell carcinoma
por: Zhang, Ze, et al.
Publicado: (2019)

Cytotoxicity and apoptotic activities of alpha-, gamma- and delta-tocotrienol isomers on human cancer cells
por: Lim, Su-Wen, et al.
Publicado: (2014)

Yeast Cell-Based Transport Assay for the Functional Characterization of Human 4F2hc-LAT1 and ‐LAT2, and LAT1 and LAT2 Substrates and Inhibitors
por: Kantipudi, Satish, et al.
Publicado: (2021)

Cys Site-Directed Mutagenesis of the Human SLC1A5 (ASCT2) Transporter: Structure/Function Relationships and Crucial Role of Cys467 for Redox Sensing and Glutamine Transport
por: Scalise, Mariafrancesca, et al.
Publicado: (2018)

A new formulation of Gamma Delta Tocotrienol has superior bioavailability compared to existing Tocotrienol-Rich Fraction in healthy human subjects
por: Meganathan, Puvaneswari, et al.
Publicado: (2015)

Delta- and gamma-tocotrienol isomers are potent in inhibiting inflammation and endothelial activation in stimulated human endothelial cells
por: Muid, Suhaila, et al.
Publicado: (2016)

ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer
por: van Geldermalsen, M, et al.
Publicado: (2016)

Synergistic Effect of Garcinol and Curcumin on Antiproliferative and Apoptotic Activity in Pancreatic Cancer Cells
por: Parasramka, Mansi A., et al.
Publicado: (2012)

Erratum to “Synergistic Effect of Garcinol and Curcumin on Antiproliferative and Apoptotic Activity in Pancreatic Cancer Cells”
por: Parasramka, Mansi A., et al.
Publicado: (2019)

Food for Bone: Evidence for a Role for Delta-Tocotrienol in the Physiological Control of Osteoblast Migration
por: Casati, Lavinia, et al.
Publicado: (2020)

Rush Hour of LATs towards Their Transport Cycle
por: Nicolàs-Aragó, Adrià, et al.
Publicado: (2021)

LAT2 regulates glutamine-dependent mTOR activation to promote glycolysis and chemoresistance in pancreatic cancer
por: Feng, Mengyu, et al.
Publicado: (2018)

Visualization of Glutamine Transporter Activities in Living Cells Using Genetically Encoded Glutamine Sensors
por: Gruenwald, Katrin, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_h89v66rgvphhlp12188f7in13e